◆タイトル：Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2025
◆商品コード：MD 1407
◆調査・発行会社：MarketsandMarkets
◆発行日：2020年2月28日
◆ページ数：260
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別） ※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はアフェレーシスの世界市場が、2019年17億ドルから2025年27憶ドルまで、年平均8.1％成長すると予測しています。本調査レポートでは、アフェレーシスの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、業界洞察、製品別(使い捨てアフェレーシス、アフェレーシス装置、膜分離機）分析、手順別（ドナー、治療薬）分析、技術別（遠心分離、膜分離）分析、用途別（血漿交換、血小板分離）分析、エンドユーザー別（病院、血液採取センター）分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・業界洞察 ・アフェレーシスの世界市場：製品別(使い捨てアフェレーシス、アフェレーシス装置、膜分離機） ・アフェレーシスの世界市場：手順別（ドナー、治療薬） ・アフェレーシスの世界市場：技術別（遠心分離、膜分離） ・アフェレーシスの世界市場：用途別（血漿交換、血小板分離） ・アフェレーシスの世界市場：エンドユーザー別（病院、血液採取センター） ・アフェレーシスの世界市場：地域別 ・競争状況 ・企業概要

“The apheresis market is projected to grow at a CAGR of 8.1%.”
The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period. The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

“In 2018, the apheresis disposables segment accounted for the largest share of the market.”
On the basis of product, the apheresis disposables segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to its recurrent use, increasing blood donations using apheresis devices, increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

“In 2018, the Automated Blood Collection (Donor Apheresis) segment accounted for the largest share of the market.”
On the basis of procedure, the automated blood collection (donor apheresis) segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to the increasing number of blood component donations using apheresis devices and the increasing demand for source plasma from biopharmaceutical companies.

“In 2018, the centrifugation segment accounted for the largest share of the market.”
On the basis of technology, the centrifugation segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components.

“In 2018, the plasmapheresis segment accounted for the largest share of the market.”
On the basis of application, the plasmapheresis segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to the increasing demand for plasma from biopharmaceutical companies and the use of plasmapheresis as a key therapeutic apheresis procedure.

“In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market.”
On the basis of end user, the blood collection centers and blood component providers segment accounted for the largest share of the apheresis market in 2018. The large share of this segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness.

“APAC is projected to witness the highest growth during the forecast period.”
The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the rapid growth in geriatric population, improving healthcare infrastructure, increasing per capita income of the middle-class population in the region, rising focus of key market players on emerging APAC countries, and the increasing accessibility to a range of products with leading players entering these lucrative geographical regions.

The breakdown of primary participants was as mentioned below:
• By Company Type: Tier 1–45%, Tier 2–30%, and Tier 3–25%
• By Designation: C-level–35%, Director Level–25%, and Others–40%
• By Region: North America–40%, Europe–20%, Asia Pacific–25%, Latin America–10%, Middle East & Africa–5%

The leading players in this market include Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan).

Research Coverage:
The report analyzes the various apheresis devices and their adoption patterns. It aims at estimating the market size and future growth potential of the apheresis market for different segments such as product, technology, procedure, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the apheresis market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the apheresis market
• Market Development: Comprehensive information on the lucrative emerging regions by product, technology, procedure, application, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the apheresis market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the apheresis market

【レポートの目次】

★調査レポート[アフェレーシスの世界市場予測：製品別(デバイス（遠心分離、膜分離）、消耗品)、手順別（ドナー、治療薬）、用途別（血漿交換、血小板分離）、技術別、エンドユーザー別（病院、血液採取センター）、地域別] ( Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2025 / MD 1407) 販売に関する免責事項

[アフェレーシスの世界市場予測：製品別(デバイス（遠心分離、膜分離）、消耗品)、手順別（ドナー、治療薬）、用途別（血漿交換、血小板分離）、技術別、エンドユーザー別（病院、血液採取センター）、地域別] ( Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2025 / MD 1407) についてEメールでお問い合わせ

---

◆H&Iグローバルリサーチ株式会社のお客様（例）◆